Blocking the path of lymphatic vessels.
作者信息
Skobe Mihaela, Dana Reza
机构信息
Mihaela Skobe is in the Department of Oncological Sciences, Mount Sinai School of Medicine, New York, New York, USA.
出版信息
Nat Med. 2009 Sep;15(9):993-4. doi: 10.1038/nm0909-993.
Abstract
摘要
相似文献
1
Blocking the path of lymphatic vessels.阻塞淋巴管通路。
Nat Med. 2009 Sep;15(9):993-4. doi: 10.1038/nm0909-993.
2
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.可变剪接的血管内皮生长因子受体-2是淋巴管生长的一种重要内源性抑制剂。
Nat Med. 2009 Sep;15(9):1023-30. doi: 10.1038/nm.2018. Epub 2009 Aug 9.
3
Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis.蛋白聚糖共受体在病理性淋巴管生成中的功能重要性
Circ Res. 2016 Jul 8;119(2):210-21. doi: 10.1161/CIRCRESAHA.116.308504. Epub 2016 May 25.
4
Genes tell lymphatics to sprout or not.基因决定淋巴管是否会生长。
Nat Immunol. 2004 Jan;5(1):11-2. doi: 10.1038/ni0104-11.
5
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.血管内皮生长因子C是胚胎静脉中最初淋巴管出芽所必需的。
Nat Immunol. 2004 Jan;5(1):74-80. doi: 10.1038/ni1013. Epub 2003 Nov 23.
6
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.淋巴管系统：发育、分子调控及其在肿瘤转移和炎症中的作用
Trends Immunol. 2004 Jul;25(7):387-95. doi: 10.1016/j.it.2004.05.003.
7
[Lymphangiogenesis].[淋巴管生成]
Nihon Yakurigaku Zasshi. 2013 May;141(5):290-1. doi: 10.1254/fpj.141.290.
8
CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.CCBE1 对于哺乳动物的淋巴血管发育是必需的，并增强了血管内皮生长因子-C 在体内的淋巴管生成作用。
Circ Res. 2011 Aug 19;109(5):486-91. doi: 10.1161/CIRCRESAHA.111.250738. Epub 2011 Jul 21.
9
Physiology. Lymphatics are in my veins.生理学。淋巴管在我的静脉里。
Science. 2013 Aug 9;341(6146):622-4. doi: 10.1126/science.1243452.
10
Targeting lymphangiogenesis to prevent tumour metastasis.靶向淋巴管生成以预防肿瘤转移。
Br J Cancer. 2006 May 22;94(10):1355-60. doi: 10.1038/sj.bjc.6603120.
引用本文的文献
1
Corneal melting following intrastromal injection of bevacizumab for corneal neovascularization.基质内注射贝伐单抗治疗角膜新生血管后发生角膜溶解。
Oman J Ophthalmol. 2025 Jun 24;18(2):205-207. doi: 10.4103/ojo.ojo_344_24. eCollection 2025 May-Aug.
2
Enhancing the Inhibition of Corneal Neovascularization Efficacy by Self-Assembled into Supramolecular Hydrogel of Anti-Angiogenic Peptide.自组装成抗血管生成肽超分子水凝胶增强角膜新生血管抑制效果。
Int J Nanomedicine. 2024 Jul 25;19:7605-7616. doi: 10.2147/IJN.S465965. eCollection 2024.
3
Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis.抗血管内皮生长因子药物治疗角膜新生血管的疗效与安全性：一项荟萃分析。
World J Clin Cases. 2023 Oct 26;11(30):7337-7349. doi: 10.12998/wjcc.v11.i30.7337.
4
Development of Osthole-Loaded Microemulsions as a Prospective Ocular Delivery System for the Treatment of Corneal Neovascularization: In Vitro and In Vivo Assessments.蛇床子素微乳剂作为治疗角膜新生血管的前瞻性眼用给药系统的研发：体外和体内评估
Pharmaceuticals (Basel). 2023 Sep 22;16(10):1342. doi: 10.3390/ph16101342.
5
Preparation and and evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization.制备及评价异甘草素眼用纳米乳剂治疗角膜新生血管。
Drug Deliv. 2022 Dec;29(1):2217-2233. doi: 10.1080/10717544.2022.2096714.
6
Immunity and pain in the eye: focus on the ocular surface.眼部免疫与疼痛：聚焦眼表面。
Clin Exp Immunol. 2022 Apr 4;207(2):149-163. doi: 10.1093/cei/uxab032.
7
Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study.角膜新生血管的流行病学及其对视力和敏感度的影响：一项14年的回顾性研究。
Front Med (Lausanne). 2021 Oct 14;8:733538. doi: 10.3389/fmed.2021.733538. eCollection 2021.
8
SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo.SKLB1002，一种有效的 VEGF 受体 2 信号抑制剂，在体外抑制内皮细胞的血管生成功能，在体内抑制眼血管生成。
Mol Med Rep. 2020 Jun;21(6):2571-2579. doi: 10.3892/mmr.2020.11056. Epub 2020 Apr 6.
9
The role of extracellular matrix in mouse and human corneal neovascularization.细胞外基质在小鼠和人眼角膜新生血管中的作用。
Sci Rep. 2019 Oct 3;9(1):14272. doi: 10.1038/s41598-019-50718-8.
10
Adolescent Onset of Localized Papillomatosis, Lymphedema, and Multiple Beta-Papillomavirus Infection: Epidermal Nevus, Segmental Lymphedema Praecox, or Verrucosis? A Case Report and Case Series of Epidermal Nevi.青少年期局限性乳头瘤病、淋巴水肿和多种β乳头瘤病毒感染：表皮痣、早发性节段性淋巴水肿还是疣病？1例病例报告及表皮痣病例系列
Dermatopathology (Basel). 2014 Oct 23;1(2):55-69. doi: 10.1159/000367967. eCollection 2014 Aug-Dec.
本文引用的文献
1
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.可变剪接的血管内皮生长因子受体-2是淋巴管生长的一种重要内源性抑制剂。
Nat Med. 2009 Sep;15(9):1023-30. doi: 10.1038/nm.2018. Epub 2009 Aug 9.
2
Corneal lymphangiogenesis: implications in immunity.角膜淋巴管生成：对免疫的影响
Semin Ophthalmol. 2009 May-Jun;24(3):135-8. doi: 10.1080/08820530902801320.
3
Corneal avascularity is due to soluble VEGF receptor-1.角膜无血管状态归因于可溶性血管内皮生长因子受体-1。
Nature. 2006 Oct 26;443(7114):993-7. doi: 10.1038/nature05249. Epub 2006 Oct 18.
4
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.角膜上皮细胞中非血管性血管内皮生长因子受体3的表达维持无血管状态和视力。
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11405-10. doi: 10.1073/pnas.0506112103. Epub 2006 Jul 18.
5
Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants.淋巴管内皮祖细胞有助于人类肾移植中的新生淋巴管生成。
Nat Med. 2006 Feb;12(2):230-4. doi: 10.1038/nm1340. Epub 2006 Jan 15.
6
Lymphangiogenesis in development and human disease.发育及人类疾病中的淋巴管生成
Nature. 2005 Dec 15;438(7070):946-53. doi: 10.1038/nature04480.
7
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages.炎症诱导的角膜淋巴管生成源于CD11b阳性巨噬细胞。
J Clin Invest. 2005 Sep;115(9):2363-72. doi: 10.1172/JCI23874.
8
Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.通过中和血管内皮生长因子（VEGF）抑制正常风险角膜移植后的血管生成和淋巴管生成可促进移植物存活。
Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2666-73. doi: 10.1167/iovs.03-1380.
9
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity.血管内皮生长因子受体-3介导角膜同种免疫反应的诱导。
Nat Med. 2004 Aug;10(8):813-5. doi: 10.1038/nm1078. Epub 2004 Jul 4.
10
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.血管内皮生长因子-C在黑色素瘤中同时诱导淋巴管生成、血管生成和巨噬细胞募集。
Am J Pathol. 2001 Sep;159(3):893-903. doi: 10.1016/S0002-9440(10)61765-8.
Zotero 插件